| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 10/03/2007 | CN101048405A Aryl-substituted piperazine derivatives |
| 10/03/2007 | CN101048369A Biphenyloxyacetic acid derivatives for the treatment of respiratory disease |
| 10/03/2007 | CN101045715A Heterocycle inhibitor for glycogen synthase kinase gsk-3 |
| 10/03/2007 | CN101045703A Method for preparing N-hydroxyamber imide ester by acetyliode-benzoic alcohot oxide |
| 10/02/2007 | US7276612 For hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides |
| 10/02/2007 | US7276610 Aryl piperidine amides |
| 10/02/2007 | US7276531 G-lactam derivatives as prostaglandin agonists |
| 10/02/2007 | US7276530 Lactam fermentation products, e.g., pyrrolooxetanediones or pyrrolothietanediones especially containing a cyclohexane or cyclohexane ring, used as antimicrobial, anticancer or antiinflammatory agents; treating drug resistant cancer |
| 10/02/2007 | CA2184049C Thermally stable storable crystalline modification of n-methyl-n-[(1s)-1-phenyl-2-((3s)-3-hydroxy-pyrrolidin-1-yl)ethyl]-2,2-diphenylacetamide and a process for its preparation |
| 09/27/2007 | WO2007109175A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 09/27/2007 | WO2007108210A1 Hair dying composition |
| 09/27/2007 | WO2007108209A1 Hair dying composition |
| 09/27/2007 | WO2007108006A1 Process for the preparation of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2, 3-dihydro-1h-pyrrolizin-5-yl acetic acid and its intermediates |
| 09/27/2007 | WO2007107319A1 Isolation, structure determination, synthesis and bioactivity of damipipecolin and damituricin |
| 09/27/2007 | WO2007107311A2 Organic sulphinic acid derivatives |
| 09/27/2007 | WO2007107008A1 Compounds and compositions for use in the prevention and treatment of disorders of fat metabolism and obesity |
| 09/27/2007 | US20070225499 Process for the Preparation of 2,2-Disubstituted Pyrroles |
| 09/27/2007 | US20070225372 Amides as Bace Inhibitors |
| 09/27/2007 | US20070225353 Process for Forming Amorphous Atorvastatin |
| 09/27/2007 | US20070225344 Sulfonamide derivatives to treat infection with hepatitis C virus |
| 09/27/2007 | US20070225296 Arylalkylamine Compound and Process for Preparing the Same |
| 09/27/2007 | US20070225170 2-Halo-6-Alkylphenyl-Substituted Tetramic Acid Derivatives |
| 09/27/2007 | US20070225167 2-Ethyl-4,6-Dimethyl-Phenyl-Substituted Tetramic Acid Derivatives as Pest Control Agents and/or Herbicides |
| 09/27/2007 | CA2645867A1 Substituted gamma lactams as prostaglandin ep2 agonists |
| 09/26/2007 | EP1837329A1 Novel heteroaryl derivative |
| 09/26/2007 | EP1837024A2 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection |
| 09/26/2007 | EP1836165A1 Dipyrrole compounds, compositions, and methods for treating cancer or viral diseases |
| 09/26/2007 | EP1836164A1 11c-labeled benzyl-lactam compounds and their use as imaging agents |
| 09/26/2007 | EP1836163A2 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 09/26/2007 | EP1836158A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation |
| 09/26/2007 | EP1699752B1 (hetero)cyclyl carboxanilides for controlling harmful fungi |
| 09/26/2007 | EP1451153B1 Nk1 antagonists |
| 09/26/2007 | EP1406873B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/26/2007 | EP1339678B1 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 09/26/2007 | EP1338588B1 Method of resolving optical isomers of amino acid derivative |
| 09/26/2007 | EP1276732B1 Amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation" |
| 09/26/2007 | EP1263726B1 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa |
| 09/26/2007 | CN101044136A Pyrrolo-naphthyl acids as pai-1 inhibitors |
| 09/26/2007 | CN101044115A Piperidines and related compounds for treatment of alzheimer's disease |
| 09/26/2007 | CN101041632A Preparation method of penem drug branched chain intermediate-mercaptan derivative |
| 09/26/2007 | CN100339352C 2-and 2,5-substituted phenylketoenols |
| 09/25/2007 | US7273878 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 09/25/2007 | US7273867 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents |
| 09/25/2007 | US7273863 Benzophenones as inhibitors of reverse transcriptase |
| 09/25/2007 | US7273856 Antagonist of tachykinins like neurokinins and drugs |
| 09/25/2007 | CA2547947C Azole derivatives as active superoxide radical inhibitors |
| 09/25/2007 | CA2415551C Aniline derivatives |
| 09/25/2007 | CA2294341C Crystalline forms of antibiotic side chain intermediates |
| 09/25/2007 | CA2256516C Peptides |
| 09/20/2007 | WO2007106705A1 Soluble epoxide hydrolase inhibitors and methods of using same |
| 09/20/2007 | WO2007105053A2 Tetralines antagonists of the h-3 receptor |
| 09/20/2007 | WO2007104361A1 Nanofibers from functionalized organic molecules |
| 09/20/2007 | WO2007104162A1 Iap bir domain binding compounds |
| 09/20/2007 | WO2007104144A1 Compounds, ionic liquids, molten salts and uses thereof |
| 09/20/2007 | US20070219375 Novel Compound and Organic Electronic Device Using the Same |
| 09/20/2007 | US20070219266 N-Acylated-3-(Benzoyl)-Pyrrolidines as 11-Beta-HSD1 Inhibitors Useful for the Treatment of Metabolic Disorders |
| 09/20/2007 | US20070219216 1-Alkylpiperazinyl-Pyrrolidin-2,5-Dione Derivatives as Adrenergic Receptor Antagonists |
| 09/20/2007 | US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both |
| 09/20/2007 | US20070218136 New mandelic acid derivatives and their use as thrombin inhibitors |
| 09/20/2007 | CA2643859A1 Soluble epoxide hydrolase inhibitors and methods of using same |
| 09/20/2007 | CA2643055A1 Tetralines antagonists of the h-3 receptor |
| 09/19/2007 | EP1834956A1 Metal complex compound and organic electroluminescent element using the same |
| 09/19/2007 | EP1834944A1 Process for preparing C7 intermediates and their use in the preparation on N-substituted pyrrole derivatives |
| 09/19/2007 | EP1834640A2 Kappa opiatagonists for treating bladder diseases |
| 09/19/2007 | EP1833782A1 Cycloalkylamine derivatives |
| 09/19/2007 | CN101039906A Process for preparing amorphous atorvastatin hemi-calcium by dissolving the salt in an organic solvent which is a mixture of an alcohol and a ketone and/or an ester and removing the solvent |
| 09/19/2007 | CN101039905A New histone deacetylases inhibitors |
| 09/19/2007 | CN101039904A Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 09/19/2007 | CN101037457A Branched polyhydroxy pyrrole derivatives and preparation method and application |
| 09/19/2007 | CN101037409A Process for the preparation of n-substituted 2-cyanopyrrolidines |
| 09/19/2007 | CN100338073C Substituted phenylacetic acids |
| 09/19/2007 | CN100338046C Antimalarial and anti-babesiosis agent and pharmaceutical compositions contg. same |
| 09/19/2007 | CN100338044C HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 09/19/2007 | CN100338031C Compounds and methods for synthesis and therapy |
| 09/19/2007 | CN100338025C Perfluoroalkylanilins |
| 09/18/2007 | US7271272 Process for preparing 4-aminomethyl-3-alkoxyiminopyrrolidine methanesulfonate |
| 09/18/2007 | US7271270 High affinity small molecule C5a receptor modulators |
| 09/18/2007 | US7271196 CETP activity inhibitors |
| 09/18/2007 | US7271172 Pyrrolidine and azetidine compounds as CCR5 antagonists |
| 09/18/2007 | CA2415097C Process and intermediate compounds for the preparation of pyrrolidines |
| 09/18/2007 | CA2291511C Process for the preparation of highly chromatic perylene pigments |
| 09/18/2007 | CA2220533C 3-amidochromanylsulfonyl(thio)ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them |
| 09/18/2007 | CA2211982C Substituted indanylidineacetylguanidines, process for their preparation,their use as medicaments or diagnostic and medicaments containing them |
| 09/18/2007 | CA2201812C 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses |
| 09/18/2007 | CA2149285C Perfluoroalkyl-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them |
| 09/18/2007 | CA2095797C Arylacetamides |
| 09/16/2007 | CA2581960A1 Iap bir domain binding compounds |
| 09/13/2007 | WO2007103584A2 Polyamides for treating human papilloma virus |
| 09/13/2007 | WO2007103223A1 Process for preparing a crystalline form of atorvastatin hemi-calcium |
| 09/13/2007 | WO2007102567A1 Process for production of 3,4-disubstituted pyrrolidine derivative and intermediate for the production |
| 09/13/2007 | WO2007102286A1 Method for producing aminoacetylpyrrolidinecarbonitrile derivative and production intermediate thereof |
| 09/13/2007 | US20070213538 Ionic Liquids Having Fluoroalkyltrifluoroborate Anions |
| 09/13/2007 | US20070213391 Furosemide modulators of hm74 |
| 09/13/2007 | US20070213364 Alkoxyphenylpropanoic Acid Derivatives |
| 09/13/2007 | US20070213348 Chemical Compounds |
| 09/13/2007 | US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 09/13/2007 | US20070213331 Beta -secretase (BACE); Alzheimer's disease; 2-(R)-[2-(S)-Amino-3-(3,5-difluorophenyl)-1-(S)-hydroxypropyl]-pyrrolidine-1-carboxylic acid tert-butyl ester |
| 09/13/2007 | US20070213329 Sulphones which modulate the action of gammasecretase |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/13/2007 | CA2645191A1 Process for producing 3,4-disubstituted pyrrolidine derivative and production intermediate thereof |